Dr. Joseph Hamati, M.D. Anesthesiology - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 S Douglas Blvd, Midwest City, OK 73130 Phone: 405-741-7722 |
John Kevin Mirjanich, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2825 Parklawn Dr, Midwest City, OK 73110 Phone: 405-360-7576 Fax: 405-360-7762 |
Dr. Xiangyang Zheng, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 2825 Parklawn Dr, Midwest City, OK 73110 Phone: 405-610-4411 Fax: 405-843-2077 |
Vernon Clifford Hofmann, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 2825 Parklawn Dr, Midwest City, OK 73110 Phone: 405-360-7576 Fax: 405-360-7762 |
News Archive
Pharmaceutical manufacturers seeking to conduct their own qualitative and quantitative analyses can now rely on a new chemometrics package that integrates with the Thermo Scientific TruScan RM handheld analyzer.
VIVUS, Inc. today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) voted against the following question: "Based on the current available data, do you believe the overall benefit-risk assessment of PHEN/TPM (QNEXA) is favorable to support its approval for the treatment of obesity in individuals with a BMI > 30 kg/m2 or > 27 kg/m2 with weight-related co-morbidities?" The three co-morbidities included hypertension, diabetes and dyslipidemia.
On 20 August 2008, cases of acute watery diarrhoea from Baghdad and Misan Province were laboratory confirmed as cholera. They constitute the first cholera cases detected in Iraq in 2008. By 28 August, seven cases had been laboratory confirmed, and a further 174 cases were suspected as cholera, bringing the total number of reported cases to 181 (128 in Missan and 53 in Baghdad).
The biomarker specialists at Biomedica Immunoassays, announced the launch of the first CE marked FGF23 (C-terminal) ELISA assay which specifically detects both intact and C-terminal fragments of FGF23 in human serum and plasma. The FGF23 ELISA assay complements the existing Biomedica assays directed against chronic kidney disease - mineral and bone disorder (CKD-MBD) in a growing collection.
› Verified 3 days ago